Thinking pink for breast cancer awareness
Key points
- Pink lights illuminating the Sundial Bridge over the Sacramento River was the culmination of Think Pink Breast Cancer Awareness Day on Thursday in Redding.
- The bridge-lighting ceremony, sponsored by MD Imaging, marked Nor-Cal Think Pink's 16th year of spreading educational information about breast cancer.
- Earlier Thursday, Nor-Cal Think Pink volunteers handed out thousands of Think Pink bags at about 50 locations across the north state.
- The organization says the best defense against the disease is early detection — when caught and treated early, breast cancer has a 98 percent cure rate.
Pink lights illuminating the Sundial Bridge over the Sacramento River was the culmination of Think Pink Breast Cancer Awareness Day on Thursday in Redding.
The bridge-lighting ceremony, sponsored by MD Imaging, marked Nor-Cal Think Pink's 16th year of spreading educational information about breast cancer. October is also Breast Cancer Awareness Month.
Earlier Thursday, Nor-Cal Think Pink volunteers handed out thousands of Think Pink bags at about 50 locations across the north state.
The organization says the best defense against the disease is early detection — when caught and treated early, breast cancer has a 98 percent cure rate.
###
Scripps Interactive Newspapers Group
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsPotential new therapy for triple-negative breast cancer shows promise in lab studies
Recent laboratory findings provide novel insight into potential new therapeutic approaches for triple-negative breast cancer, a particularly difficult to treat and aggressive form of the disease. In a recent study…
28 October 2015
NewsUGR scientists patent an effective drug for treating breast, colon, and skin cancers
Scientists from the University of Granada (UGR) have patented an effective drug for treating cancer stem cells (CSCs) in breast, colon, and skin cancers. The researchers have proved the anti-tumor effects of the drug on…
21 October 2015
GuideDecoding the microbial signature of aggressive form of breast cancer
Cancer is a result of normal cellular functions going wildly awry on a genetic level. That fact has been known for some time, but increasing evidence is showing that the human microbiome, the diverse population of…
